The DOI matches its Crossref record; 426 of the 426 references it cites were found in a registry or an index.
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Open accessAbstract
Several immune and immunocompetent cells, including dendritic cells, macrophages, adipocytes, natural killer cells, T cells, and B cells, are significantly correlated with the complex discipline of oncology. Cytotoxic innate and adaptive immune cells can block tumor proliferation, and others can prevent the immune system from rejecting malignant cells and provide a favorable environment for tumor progression. These cells communicate with the microenvironment through cytokines, a chemical messenger, in an endocrine, paracrine, or autocrine manner. These cytokines play an important role in health and disease, particularly in host immune responses to infection and inflammation. They include chemokines, interleukins (ILs), adipokines, interferons, colony-stimulating factors (CSFs), and tumor necrosis factor (TNF), which are produced by a wide range of cells, including immune cells, such as macrophages, B-cells, T-cells, and mast cells, as well as endothelial cells, fibroblasts, a variety of stromal cells, and some cancer cells. Cytokines play a crucial role in cancer and cancer-related inflammation, with direct and indirect effects on tumor antagonistic or tumor promoting functions. They have been extensively researched as immunostimulatory mediators to promote the generation, migration and recruitment of immune cells that contribute to an effective antitumor immune response or pro-tumor microenvironment. Thus, in many cancers such as breast cancer, cytokines including leptin, IL-1B, IL-6, IL-8, IL-23, IL-17, and IL-10 stimulate while others including IL-2, IL-12, and IFN-γ, inhibit cancer proliferation and/or invasion and enhance the body’s anti-tumor defense. Indeed, the multifactorial functions of cytokines in tumorigenesis will advance our understanding of cytokine crosstalk pathways in the tumor microenvironment, such as JAK/STAT, PI3K, AKT, Rac, MAPK, NF-κB, JunB, cFos, and mTOR, which are involved in angiogenesis, cancer proliferation and metastasis. Accordingly, targeting and blocking tumor-promoting cytokines or activating and amplifying tumor-inhibiting cytokines are considered cancer-directed therapies. Here, we focus on the role of the inflammatory cytokine system in pro- and anti-tumor immune responses, discuss cytokine pathways involved in immune responses to cancer and some anti-cancer therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 426
Human Tumor Antigens and Cancer Immunotherapy
Vigneron, N. (2015) · BioMed Research International · doi:10.1155/2015/948501 · Cited by 228
The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis
Carmi, Y., Voronov, E., Dotan, S., Lahat, N., Rahat, M. A., Fogel, M., Huszar, M., White, M. R., Dinarello, C. A., & Apte, R. N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901511 · Cited by 224
CD4+ T‐regulatory cells: toward therapy for human diseases
Allan, S. E., Broady, R., Gregori, S., Himmel, M. E., Locke, N., Roncarolo, M. G., Bacchetta, R., & Levings, M. K. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00634.x · Cited by 223
Naing, A., Papadopoulos, K. P., Autio, K. A., Ott, P. A., Patel, M. R., Wong, D. J., Falchook, G. S., Pant, S., Whiteside, M., Rasco, D. R., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.1106 · Cited by 222
Petreaca, M. L., Yao, M., Liu, Y., DeFea, K., & Martins-Green, M. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0004 · Cited by 219
Singh, J. K., Farnie, G., Bundred, N. J., Simões, B. M., Shergill, A., Landberg, G., Howell, S. J., & Clarke, R. B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1063 · Cited by 217
Interleukin-12: Functional activities and implications for disease
Zundler, S., & Neurath, M. F. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.003 · Cited by 212
The Structure of Interleukin-2 Complexed with Its Alpha Receptor
Rickert, M., Wang, X., Boulanger, M. J., Goriatcheva, N., & Garcia, K. C. (2005) · Science · doi:10.1126/science.1109745 · Cited by 212
Murphy, C., McGurk, M., Pettigrew, J., Santinelli, A., Mazzucchelli, R., Johnston, P. G., Montironi, R., & Waugh, D. J. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1518 · Cited by 211
The Role of IL-1β in the Early Tumor Cell–Induced Angiogenic Response
Carmi, Y., Dotan, S., Rider, P., Kaplanov, I., White, M. R., Baron, R., Abutbul, S., Huszar, M., Dinarello, C. A., Apte, R. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202769 · Cited by 209
Friedmann, M. C., Migone, T. S., Russell, S. M., & Leonard, W. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2077 · Cited by 203
Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α
Robinson, S. C., Scott, K. A., & Balkwill, F. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2<404::aid-immu404>3.0.co;2-x · Cited by 201
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
Shchors, K., Shchors, E., Rostker, F., Lawlor, E. R., Brown-Swigart, L., & Evan, G. I. (2006) · Genes & Development · doi:10.1101/gad.1455706 · Cited by 200
Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β
Kim, J.-E., Phan, T. X., Nguyen, V. H., Dinh-Vu, H.-V., Zheng, J. H., Yun, M., Park, S.-G., Hong, Y., Choy, H. E., Szardenings, M., et al. (2015) · Theranostics · doi:10.7150/thno.11432 · Cited by 200
Role of interleukin-10 in breast cancer
Hamidullah, Changkija, B., & Konwar, R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1855-x · Cited by 195
Schumacher, C., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10542 · Cited by 191
IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18
Cai, G., Kastelein, R. A., & Hunter, C. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<2658::aid-immu2658>3.0.co;2-g · Cited by 191
The role of IL-1B in breast cancer bone metastasis
Tulotta, C., & Ottewell, P. (2018) · Endocrine-Related Cancer · doi:10.1530/erc-17-0309 · Cited by 191
Yang, C., He, L., He, P., Liu, Y., Wang, W., He, Y., Du, Y., & Gao, F. (2015) · Medical Oncology · doi:10.1007/s12032-014-0352-6 · Cited by 189
Storci, G., Sansone, P., Mari, S., D'Uva, G., Tavolari, S., Guarnieri, T., Taffurelli, M., Ceccarelli, C., Santini, D., Chieco, P., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22264 · Cited by 189
Serum Interleukin 6, Plasma VEGF, Serum VEGF, and VEGF Platelet Load in Breast Cancer Patients
Benoy, I., Salgado, R., Colpaert, C., Weytjens, R., Vermeulen, P. B., & Dirix, L. Y. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.n.008 · Cited by 188
Wu, J., Gao, F.-X., Wang, C., Qin, M., Han, F., Xu, T., Hu, Z., Long, Y., He, X.-M., Deng, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1310-0 · Cited by 187
Interleukin-8 in Breast Cancer Progression
Todorović-Raković, N., & Milovanović, J. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0023 · Cited by 186
de Rham, C., Ferrari-Lacraz, S., Jendly, S., Schneiter, G., Dayer, J.-M., & Villard, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2336 · Cited by 184
Benevides, L., da Fonseca, D. M., Donate, P. B., Tiezzi, D. G., De Carvalho, D. D., de Andrade, J. M., Martins, G. A., & Silva, J. S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0054 · Cited by 182
Torrey, H., Butterworth, J., Mera, T., Okubo, Y., Wang, L., Baum, D., Defusco, A., Plager, S., Warden, S., Huang, D., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf8608 · Cited by 182
Akt/PKB: one kinase, many modifications
Risso, G., Blaustein, M., Pozzi, B., Mammi, P., & Srebrow, A. (2015) · Biochemical Journal · doi:10.1042/bj20150041 · Cited by 178
The Signaling and Biological Implications of FAK Overexpression in Cancer
Siesser, P. M. F., & Hanks, S. K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0456 · Cited by 175
Callahan, M. K., Williamson, P., & Schlegel, R. A. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400690 · Cited by 175
The Leptin Receptor Complex: Heavier Than Expected?
Wauman, J., Zabeau, L., & Tavernier, J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00030 · Cited by 174
IL-6: The Link Between Inflammation, Immunity and Breast Cancer
Chen, J., Wei, Y., Yang, W., Huang, Q., Chen, Y., Zeng, K., & Chen, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903800 · Cited by 174
Zhang, M., Huang, L., Ding, G., Huang, H., Cao, G., Sun, X., Lou, N., Wei, Q., Shen, T., Xu, X., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000308 · Cited by 172
Panduro, M., Benoist, C. O., & Mathis, D. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800618115 · Cited by 170
Cancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors
Erez, N., Glanz, S., Raz, Y., Avivi, C., & Barshack, I. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.089 · Cited by 167
Gonzalez-Perez, R. R., Xu, Y., Guo, S., Watters, A., Zhou, W., & Leibovich, S. J. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.003 · Cited by 167
Pan, B., Shen, J., Cao, J., Zhou, Y., Shang, L., Jin, S., Cao, S., Che, D., Liu, F., & Yu, Y. (2015) · Scientific Reports · doi:10.1038/srep16053 · Cited by 165
Interaction between the Components of the Interferon γ Receptor Complex
Kotenko, S. V., Izotova, L. S., Pollack, B. P., Mariano, T. M., Donnelly, R. J., Muthukumaran, G., Cook, J. R., Garotta, G., Silvennoinen, O., Ihle, J. N., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.20915 · Cited by 164
Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer
Salazar, Y., Zheng, X., Brunn, D., Raifer, H., Picard, F., Zhang, Y., Winter, H., Guenther, S., Weigert, A., Weigmann, B., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci124037 · Cited by 164
Yoon, S., Woo, S. U., Kang, J. H., Kim, K., Kwon, M.-H., Park, S., Shin, H.-J., Gwak, H.-S., & Chwae, Y.-J. (2010) · Autophagy · doi:10.4161/auto.6.8.13547 · Cited by 163
Phenotype Switching in Melanoma: Implications for Progression and Therapy
Li, F. Z., Dhillon, A. S., Anderson, R. L., McArthur, G., & Ferrao, P. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00031 · Cited by 163
Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer
Song, M., Ping, Y., Zhang, K., Yang, L., Li, F., Zhang, C., Cheng, S., Yue, D., Maimela, N. R., Qu, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0596 · Cited by 163
Chemokines and neuromodulation
Mélik-Parsadaniantz, S., & Rostène, W. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.022 · Cited by 162
Wang, L., Zhao, Y., Liu, Y. F., Akiyama, K., Chen, C., Qu, C., Jin, Y. J., & Shi, S. (2013) · Stem Cells · doi:10.1002/stem.1388 · Cited by 162
Xiao, P. G., Long, X., Zhang, L., Ye, Y., Guo, J., Liu, P., Zhang, R., Ning, J., Yu, W., Wei, F., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1440166 · Cited by 162
γδ T Cells: The Ideal Tool for Cancer Immunotherapy
Yazdanifar, M., Barbarito, G., Bertaina, A., & Airoldi, I. (2020) · Cells · doi:10.3390/cells9051305 · Cited by 162
Li, H., Xiao, H., Lin, L., Jou, D., Kumari, V., Lin, J., & Li, C. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401144z · Cited by 161
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis
Teng, M. W. L., Andrews, D. M., McLaughlin, N. M., von Scheidt, B., Ngiow, S. F., Möller, A., Hill, G. R., Iwakura, Y., Oft, M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003251107 · Cited by 161
Berner, V., Liu, H., Zhou, Q., Alderson, K. L., Sun, K., Weiss, J. M., Back, T. C., Longo, D. L., Blazar, B. R., Wiltrout, R. H., et al. (2007) · Nature Medicine · doi:10.1038/nm1554 · Cited by 161
Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
Yan, J., Smyth, M. J., & Teng, M. W. L. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028530 · Cited by 161
Inflammation and cancer: Breast cancer as a prototype
Mantovani, A., Marchesi, F., Porta, C., Sica, A., & Allavena, P. (2007) · The Breast · doi:10.1016/j.breast.2007.07.013 · Cited by 159
Cochaud, S., Giustiniani, J., Thomas, C., Laprévotte, E., Garbar, C., Savoye, A.-M., Curé, H., Mascaux, C., Alberici, G. F., Bonnefoy, N., et al. (2013) · Scientific Reports · doi:10.1038/srep03456 · Cited by 158
Leptin-Induced JAK/STAT Signaling and Cancer Growth
Mullen, M., & Gonzalez-Perez, R. R. (2016) · Vaccines · doi:10.3390/vaccines4030026 · Cited by 155
Devin, A., Lin, Y., Yamaoka, S., Li, Z., Karin, M., & Liu, Z.-G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3986-3994.2001 · Cited by 154
The role of interferon-gamma on immune and allergic responses
Teixeira, L. K., Fonseca, B. P., Barboza, B. A., & Viola, J. P. B. (2005) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762005000900024 · Cited by 154
Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
Han, Z., Li, Y.-B., Yang, L., Cheng, H., Liu, X., & Chen, H. (2021) · Molecules · doi:10.3390/molecules27010137 · Cited by 151
Paul, S., Chhatar, S., Mishra, A., & Lal, G. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0697-7 · Cited by 150
Zwirner, N. W., & Ziblat, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00025 · Cited by 150
Structure of the IFNγ receptor complex guides design of biased agonists
Mendoza, J. L., Escalante, N. K., Jude, K. M., Bellón, J. S., Su, L., Horton, T. M., Tsutsumi, N., Berardinelli, S. J., Haltiwanger, R. S., Piehler, J., et al. (2019) · Nature · doi:10.1038/s41586-019-0988-7 · Cited by 150
Tumor Rejection by Disturbing Tumor Stroma Cell Interactions
Ibe, S., Qin, Z., Schüler, T., Preiß, S., & Blankenstein, T. J. F. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1549 · Cited by 149
Barbieri, I., Pensa, S., Pannellini, T., Quaglino, E., Maritano, D., Demaria, M., Voster, A., Turkson, J., Cavallo, F., Watson, C. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2840 · Cited by 148 · cited 4×
“Source Targets Action Receptors Pathways Functions IL-10 Th2, Th1, Treg [178], Th17, and also by CD8+ T cells, monocytes, macrophages, DCs [179], B cells [180], mast cells, eosinophils [181], keratinocytes, epithelial cells, and even some tumor cells [182,183] DCs [184], T, B, NK, Treg, mast, dendritic cells, M2/TAM l…”
BackgroundInfluentialInterferon-γ is an autocrine mediator for dendritic cell maturation
Pan, J., Zhang, M., Wang, J., Wang, Q., Xia, D., Sun, W., Zhang, L., Yu, H. C., Liu, Y.-J., & Cao, X. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.05.003 · Cited by 144
Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-γ, IL-2 and IL-2R
Zhao, J., Zhao, J., & Perlman, S. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046241 · Cited by 142
Development and Characterization of High Affinity Leptins and Leptin Antagonists
Shpilman, M., Niv‐Spector, L., Katz, M. N., Varol, C., Solomon, G., Ayalon-Soffer, M., Boder, E. T., Halpern, Z., Elinav, E., & Gertler, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.196402 · Cited by 142
Regulation of estrogen synthesis in postmenopausal women
Purohit, A., & Reed, M. J. (2002) · Steroids · doi:10.1016/s0039-128x(02)00046-6 · Cited by 140
Frankenberger, C. A., Rabe, D. C., Bainer, R. O., Sankarasharma, D., Chada, K. K., Krausz, T. N., Gilad, Y., Becker, L., & Rosner, M. R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3394 · Cited by 140
Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer
Reis, S. T., Leite, K. R. M., Piovesan, L. F., Pontes‐Júnior, J., Viana, N. I., Abe, D. K., Crippa, A., Moura, C. M., Adonias, S. P., Srougi, M., et al. (2012) · BMC Urology · doi:10.1186/1471-2490-12-18 · Cited by 140
Huang, W., Chen, Z., Zhang, L., Tian, D., Wang, D. W., Fan, D., Wu, K., & Xia, L. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.058 · Cited by 139
Chan, T. C.-C., Hawkes, J. E., & Krueger, J. G. (2018) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622318759282 · Cited by 138
Mouse IL-17: A Cytokine Preferentially Expressed by αβTCR+CD4—CD8— T Cells
Kennedy, J., Rossi, D. L., Zurawski, S., Vega, F. V., Kastelein, R. A., Wagner, J., Hannum, C. H., & Zlotnik, A. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.611 · Cited by 136
Modi, W. S., Dean, M. C., Seuánez, H., Mukaida, N., Matsushima, K., & O'Brien, S. (1990) · Human Genetics · doi:10.1007/bf00208938 · Cited by 134
Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
Kolb, R. H., Kluz, P., Tan, Z. W., Borcherding, N. C., Bormann, N. L., Vishwakarma, A., Balcziak, L. K., Zhu, P., Davies, B. S. J., Gourronc, F. A., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0592-6 · Cited by 132
The Role of TNF and Its Family Members in Inflammation and Cancer: Lessons from Gene Deletion
Aggarwal, B. B., Shishodia, S., Ashikawa, K., & Bharti, A. C. (2002) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010023344571 · Cited by 131
Naing, A., Wong, D. J. L., Infante, J. R., Korn, W. M., Aljumaily, R. M., Papadopoulos, K. P., Autio, K. A., Pant, S., Bauer, T. M., Drakaki, A., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30514-5 · Cited by 131
Phenotypic and functional characterization of human CD25+ B cells
Brisslert, M., Bokarewa, M. I., Larsson, P., Wing, K., Collins, L. V., & Tarkowski, A. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02331.x · Cited by 127
Al-Hussaniy, H. A., Hany Akeel Al-hussainy, H.-A. 1.-2.-6., Alburghaif, A. H., & Naji, M. A. (2021) · Journal of Medicine and Life · doi:10.25122/jml-2021-0153 · Cited by 127
TNF Blockade: An Inflammatory Issue
Aggarwal, B. B., Shishodia, S., Takada, Y., Jackson-Bernitsas, D., Ahn, K. S., Sethi, G., & Ichikawa, H. (2006) · Springer eBooks · doi:10.1007/3-540-37673-9_10 · Cited by 125
Fuentes‐Mattei, E., Velázquez-Torres, G., Phan, L. M., Zhang, F., Chou, P., Shin, J., Choi, H. H., Chen, J., Zhao, R., Chen, J., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju158 · Cited by 124
Leptin Mediates Tumor–Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells
Barone, I., Catalano, S., Gelsomino, L., Marsico, S., Giordano, C., Panza, S., Bonofiglio, D., Bossi, G., Covington, K. R., Fuqua, S. A. W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2558 · Cited by 123
Raghu, H., Sodadasu, P. K., Malla, R. R., Gondi, C. S., Estes, N. C., & Rao, J. S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-647 · Cited by 122
Liu, W., Lu, X., Shi, P., Yang, G., Zhou, Z., Li, W., Mao, X., Jiang, D., & Chen, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-58642-y · Cited by 122
Granucci, F., Zanoni, I., Feau, S., & Ricciardi‐Castagnoli, P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg261 · Cited by 121
Santer, F. R., Malinowska, K., Čulig, Z., & Cavarretta, I. T. R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0200 · Cited by 120
Leptin–cytokine crosstalk in breast cancer
Newman, G. W., & Gonzalez-Perez, R. R. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.025 · Cited by 119
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice
Thiem, S., Pierce, T. P., Palmieri, M., Putoczki, T. L., Büchert, M., Preaudet, A., Farid, R., Love, C., Catimel, B., Lei, Z., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65086 · Cited by 119
Leptin and Cancer: Updated Functional Roles in Carcinogenesis, Therapeutic Niches, and Developments
Lin, T., & Hsiao, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062870 · Cited by 118
IL-17 Promotes Angiogenic Factors IL-6, IL-8, and Vegf Production via Stat1 in Lung Adenocarcinoma
Huang, Q., Duan, L., Qian, X., Fan, J., Lv, Z., Zhang, X., Han, J., Wu, F., Guo, M., Hu, G., et al. (2016) · Scientific Reports · doi:10.1038/srep36551 · Cited by 117
Wolczyk, D., Zaremba-Czogalla, M., Hryniewicz-Jankowska, A., Tabola, R., Grabowski, K., Sikorski, A. F., & Augoff, K. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0280-x · Cited by 116
Regulation of IFN-γ Signaling Is Essential for the Cytotoxic Activity of CD8+ T Cells
Tau, G. Z., Cowan, S., Weisburg, J. H., Braunstein, N. S., & Rothman, P. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5574 · Cited by 116
Cohen, E. N., Gao, H., Anfossi, S., Mego, M., Reddy, N. G., Debeb, B. G., Giordano, A., Tin, S., Wu, Q., Garza, R. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132710 · Cited by 116
Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor
Macdiarmid, F., Wang, D. Y., Duncan, L., Purohit, A., Ghilchik, M. W., & Reed, M. J. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90181-3 · Cited by 115
Schmid, M. C., Avraamides, C. J., Foubert, P., Shaked, Y., Kang, S. W., Kerbel, R. S., & Varner, J. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0588 · Cited by 115
Antoniv, T. T., & Ivashkiv, L. B. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03402.x · Cited by 114
Bekaii‐Saab, T., Roda, J. M., Guenterberg, K. D., Ramaswamy, B., Young, D. C., Ferketich, A. K., Lamb, T., Grever, M. R., Shapiro, C. L., & Carson, W. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0820 · Cited by 113
Interleukin‐6‐Mediated Autocrine Growth Promotion in Human Glioblastoma Multiforme Cell Line U87MG
Goswami, S. K., Gupta, A., & Sharma, S. K. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71051837.x · Cited by 113
Jang, J., Kim, D.-H., Lim, J. M., Lee, J. W., Jeong, S. J., Kim, K. P., & Surh, Y. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2288 · Cited by 111
Association of Leptin With Obesity and Insulin Resistance
Kumar, R., Mal, K., Razaq, M. K., Magsi, M., Memon, M. K., Memon, S., Afroz, M. N., Siddiqui, H. F., & Rizwan, A. (2020) · Cureus · doi:10.7759/cureus.12178 · Cited by 111
Santander, A. M., López-Ocejo, O., Casas, O., Agostini, T., Sanchez, L., Lamas-Basulto, E., Carrió, R., Cleary, M. P., Gonzalez-Perez, R. R., & Torroella‐Kouri, M. (2015) · Cancers · doi:10.3390/cancers7010143 · Cited by 110
Oh, K., Lee, O.-Y., Park, Y., Seo, M. W., & Lee, D. (2016) · BMC Cancer · doi:10.1186/s12885-016-2746-7 · Cited by 110
IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines
Jia, Z., Ragoonanan, D. S., Mahadeo, K. M., Gill, J. B., Gorlick, R. G., Shpal, E., & Li, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952231 · Cited by 109
Thiel, D. J., Du, M. L., Walter, R., D'Arcy, A., Chene, C., Fountoulakis, M., Garotta, G., Winkler, F., & Ealick, S. E. (2000) · Structure · doi:10.1016/s0969-2126(00)00184-2 · Cited by 108
Blackman, M. A., Tigges, M. A., Minie, M. E., & Koshland, M. E. (1986) · Cell · doi:10.1016/0092-8674(86)90625-2 · Cited by 108
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease
Almradi, A., Hanžel, J., Sedaño, R., Parker, C. E., Feagan, B. G., Ma, C., & Jairath, V. (2020) · BioDrugs · doi:10.1007/s40259-020-00451-w · Cited by 108
Ferrer, I., Alcántara, S., Ballabriga, J., Olivé, M., Blanco, R., Rivera, R., Carmona, M., Berruezo, M., Pitarch, S., & Planas, A. M. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00009-3 · Cited by 107
Razaghi, A., Owens, L., & Heimann, K. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.10.022 · Cited by 102
Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells
Zhang, Z., Lin, G., Yan, Y., Li, X., Hu, Y., Wang, J., Yin, B., Wu, Y., Li, Z., & Yang, X. (2018) · Oncogene · doi:10.1038/s41388-018-0221-4 · Cited by 102
Structure and Mechanism of Receptor Sharing by the IL-10R2 Common Chain
Yoon, S., Jones, B. C., Logsdon, N. J., Harris, B. D., Deshpande, A. A., Radaeva, S., Halloran, B., Gao, B., & Walter, M. R. (2010) · Structure · doi:10.1016/j.str.2010.02.009 · Cited by 101
Association between serum leptin levels and breast cancer risk
Pan, H., Deng, L., Cui, J., Shi, L., Yang, Y., Luo, J.-H., Qin, D., & Wang, L. (2018) · Medicine · doi:10.1097/md.0000000000011345 · Cited by 101
Lo, U., Pong, R.-C., Yang, D., Gandee, L., Hernandez, E., Dang, A., Lin, C.-J., Santoyo, J., Ma, S., Sonavane, R., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2207 · Cited by 101
Andò, S., Barone, I., Giordano, C., Bonofiglio, D., & Catalano, S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00340 · Cited by 100
Crawley, J. B., Williams, L. M., Mander, T., Brennan, F. M., & Foxwell, B. M. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16357 · Cited by 99
Du, J.-W., Xu, K., Fang, L., & Qi, X.-L. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1036 · Cited by 98
Harvat, B. L., Seth, P. K., & Jetten, A. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201055 · Cited by 98
Cao, X., Leonard, K., Collins, L. I., Cai, S. F., Mayer, J. C., Payton, J. E., Walter, M. J., Piwnica-Worms, D. R., Schreiber, R. D., & Ley, T. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1145 · Cited by 96
Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer
Lipsey, C. C., Harbuzariu, A., Daley-Brown, D. S., & Gonzalez-Perez, R. R. (2016) · World Journal of Methodology · doi:10.5662/wjm.v6.i1.43 · Cited by 96
Rubio, M. F., Werbajh, S., Cafferata, E. G. A., Quaglino, A., Coló, G. P., Nojek, I. M., Kordon, E. C., Nahmod, V. E., & Costas, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1209176 · Cited by 95
Interferon gamma in autoimmunity: A complicated player on a complex stage
Lees, J. R. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.014 · Cited by 95
Schraufstätter, I. U., Trieu, K., Zhao, M., Rose, D. M., Terkeltaub, R. A., & Burger, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6714 · Cited by 91
Cui, H., Cai, F., & Belsham, D. D. (2006) · The FASEB Journal · doi:10.1096/fj.06-5989fje · Cited by 91
Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification
Hou, Z., Falcone, D. J., Subbaramaiah, K., & Dannenberg, A. J. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr027 · Cited by 91
Suryawanshi, A. S., Veiga‐Parga, T., Reddy, P. B. J., Rajasagi, N. K., & Rouse, B. T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102602 · Cited by 87
Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity
Delort, L., Rossary, A., Farges, M., Vasson, M., & Caldefie‐Chezet, F. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.04.012 · Cited by 85
Self-citationShibayama, O., Yoshiuchi, K., Inagaki, M., Matsuoka, Y., Yoshikawa, E., Sugawara, Y., Akechi, T., Wada, N., Imoto, S., Murakami, K., et al. (2014) · Cancer Medicine · doi:10.1002/cam4.174 · Cited by 84
Bohrer, L. R., & Schwertfeger, K. L. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0275 · Cited by 83
Escobar, P., Bouclier, C., Serret, J., Bièche, I., Brigitte, M., Caicedo, A., Sanchez, E., Vacher, S., Vignais, M., Bourin, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4732 · Cited by 82
Widowati, W., Jasaputra, D. K., Sumitro, S. B., Widodo, M. A., Mozef, T., Rizal, R., Kusuma, H. S. W., Laksmıtawatı, D. R., Murti, H., Bachtiar, I., et al. (2020) · African Health Sciences · doi:10.4314/ahs.v20i2.36 · Cited by 82
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity
Giordano, C., Chemi, F., Panza, S., Barone, I., Bonofiglio, D., Lanzino, M., Cordella, A., Campana, A., Hashim, A., Rizza, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6014 · Cited by 81
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
Martinenaite, E., Ahmad, S. M., Hansen, M., Met, Ö., Westergaard, M. C. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, I. M., & Andersen, M. H. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1238541 · Cited by 81
Cytokines driving breast cancer stemness
Chin, A. R., & Wang, S. E. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.024 · Cited by 80
Multiple Signaling Pathways of Human Interleukin-8 Receptor A
Richardson, R. M., Ali, H., Pridgen, B. C., Haribabu, B., & Snyderman, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10690 · Cited by 80
Yang, M., Zhang, G., Wang, Y., He, M., Xu, Q., Lu, J., Liu, H., & Xu, C. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-1026-0 · Cited by 80
Oh, K., Ko, E., Kim, H. S., Park, A. K., Moon, H., Noh, D., & Lee, D. (2011) · Breast Cancer Research · doi:10.1186/bcr3034 · Cited by 79
IκBζ augments IL-12– and IL-18–mediated IFN-γ production in human NK cells
Kannan, Y., Yu, J., Raices, R. M., Seshadri, S., Wei, M., Caligiuri, M. A., & Wewers, M. D. (2011) · Blood · doi:10.1182/blood-2010-07-294702 · Cited by 78
Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation
Barchetta, I., Cimini, F. A., Ciccarelli, G., Baroni, M. G., & Cavallo, M. G. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01052-3 · Cited by 77
Leptin and cancer: from cancer stem cells to metastasis
Park, J., & Scherer, P. E. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0163 · Cited by 77
Lang, K., Niggemann, B., Zänker, K. S., & Entschladen, F. (2002) · International Journal of Cancer · doi:10.1002/ijc.10424 · Cited by 76
García‐Tuñón, I., Ricote, M., Ruiz, A., Fraile, B., Paniagua, R., & Royuela, M. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02178.x · Cited by 76
Reed, J. R., Leon, R. P., Hall, M. K., & Schwertfeger, K. L. (2009) · Breast Cancer Research · doi:10.1186/bcr2246 · Cited by 76
The role of IL17B-IL17RB signaling pathway in breast cancer
Alinejad, V., Dolati, S., Motallebnezhad, M., & Yousefi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.120 · Cited by 76
Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer
Maharjan, C. K., Mo, J., Wang, L. A., Kim, M., Wang, S., Borcherding, N. C., Vikas, P., & Zhang, W. (2021) · Cancers · doi:10.3390/cancers14010206 · Cited by 76
Ning, Y., Cui, Y., Li, X., Cao, X., Chen, A., Xu, C., Cao, J., & Luo, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.022 · Cited by 75
Nie, W., Yu, T., Sang, Y., & Gao, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.048 · Cited by 74
Wanninger, J., Neumeier, M., Weigert, J., Bauer, S., Weiß, T. S., Schäffler, A., Krempl, C., Bleyl, C., Aslanidis, C., Schölmerich, J., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90644.2008 · Cited by 73
Adris, S., Klein, S., Jasnis, M. A., Chuluyán, E., Ledda, M. F., Bravo, A., Carbone, C., Chernajovsky, Y., & Podhajcer, O. L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301012 · Cited by 72
Muromoto, R., Hirao, T., Tawa, K., Hirashima, K., Kon, S., Kitai, Y., & Matsuda, T. (2016) · International Immunology · doi:10.1093/intimm/dxw011 · Cited by 72
Yui, M. A., Sharp, L. L., Havran, W. L., & Rothenberg, E. V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4691 · Cited by 71
Oka, N., Markova, T., Tsuzuki, K., Li, W., El‐Darawish, Y., Pencheva-Demireva, M., Yamanishi, K., Yamanishi, H., Sakagami, M., Tanaka, Y., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02553-4 · Cited by 71
Th1 cytokine-based immunotherapy for cancer
Xu, H. (2014) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60305-2 · Cited by 70
Paulitti, A., Andreuzzi, E., Bizzotto, D., Pellicani, R., Tarticchio, G., Marastoni, S., Pastrello, C., Jurišica, I., Ligresti, G., Bucciotti, F., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0107-x · Cited by 70
Wang, T., Ge, Y., Xiao, M., Lopez‐Coral, A., Azuma, R., Somasundaram, R., Zhang, G., Wei, Z., Xu, X., Rauscher, F. J., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.01005.x · Cited by 69
Ben‐Baruch, A. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0094-3 · Cited by 69
TGF-β and Cancer Immunotherapy
Maruyama, T., Chen, W., & Shibata, H. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00966 · Cited by 69
Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment
Poggi, A. D., & Giuliani, M. (2016) · Vaccines · doi:10.3390/vaccines4040041 · Cited by 68
Liaskou, E., Patel, S. R., Webb, G. J., Dimakou, D. B., Akiror, S., Krishna, M., Mells, G. F., Jones, D. E., Bowman, S., Barone, F., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.020 · Cited by 68
Regulation of Interleukin-12 Production in Antigen-Presenting Cells
Zheng, H., Ban, Y., Wei, F., & Ma, X. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_6 · Cited by 68
Chen, X., Chang, L., Li, X., Huang, J., Yang, L., Lai, X., Huang, Z., Wang, Z., Wu, X., Zhao, J. J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02121 · Cited by 67
Chen, Q., Wang, J., Zhang, Q., Zhang, J., Lou, Y., Yang, J., Chen, Y., Wei, T., Zhang, J., Fu, Q., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0595-2 · Cited by 67
Huang, S., Wei, P., Hwang‐Verslues, W. W., Kuo, W., Jeng, Y., Hu, C., Shew, J., Huang, C., Chang, K., Lee, E. Y., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606914 · Cited by 66
Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC
Huang, J., Lan, X., Wang, T., Lu, H., Cao, M., Yan, S., Cui, Y., Jia, D., Cai, L., & Xing, Y. (2019) · Oncogene · doi:10.1038/s41388-019-1099-5 · Cited by 64
Diaz-Montero, C. M., El-Naggar, S. A., Khami, A. A., Naggar, R. A. R. E., Montero, A. J., Cole, D. J., & Salem, M. L. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0394-0 · Cited by 63
Leptin and breast cancer: an overview
Artaç, M., & Altundağ, K. (2011) · Medical Oncology · doi:10.1007/s12032-011-0056-0 · Cited by 62
STAT3 can serve as a hit in the process of malignant transformation of primary cells
Demaria, M., Misale, S., Giorgi, C., Miano, V., Camporeale, A., Campisi, J., Pinton, P., & Poli, V. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.20 · Cited by 61
Rubinstein-Achiasaf, L., Morein, D., Ben-Yaakov, H., Liubomirski, Y., Meshel, T., Elbaz, E., Dorot, O., Pichinuk, E., Gershovits, M., Weil, M., et al. (2021) · Cancers · doi:10.3390/cancers13061472 · Cited by 61
Immunologic profile of excessive body weight
Sharabiani, M. T. A., Vermeulen, R. C. H., Scoccianti, C., Hosnijeh, F. S., Minelli, L., Sacerdote, C., Palli, D., Krogh, V., Tumino, R., Chiodini, P., et al. (2011) · Biomarkers · doi:10.3109/1354750x.2010.547948 · Cited by 60
Innate lymphoid cells in tissue homeostasis and diseases
Ignácio, A., Breda, C. N. D. S., & Câmara, N. O. S. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i23.979 · Cited by 60
Avtanski, D. B., Nagalingam, A., Bonner, M. Y., Arbiser, J. L., Saxena, N. K., & Sharma, D. (2015) · Oncotarget · doi:10.18632/oncotarget.4937 · Cited by 59
Zhang, L., Li, J., Li, L., Zhang, J., Wang, X., Yang, C., Li, Y., Lan, F., & Lin, P. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu017 · Cited by 59
Cytokines facilitate chemotactic motility of breast carcinoma cells
Arihiro, K., Oda, H., Kaneko, M., & Inai, K. (2000) · Breast Cancer · doi:10.1007/bf02967464 · Cited by 59
Ma, L., Lan, F., Zheng, Z., Xie, F., Wang, L., Liu, W., Han, J., Zheng, F., Xie, Y., & Huang, Q. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-79 · Cited by 59
Olea‐Flores, M., Zuñiga‐Eulogio, M. D., Tacuba-Saavedra, A., Bueno-Salgado, M., Sánchez-Carvajal, A., Vargas-Santiago, Y., Catalán, M. A. M., Salazar, E. P., García-Hernández, A. P., Padilla‐Benavides, T., et al. (2019) · Cells · doi:10.3390/cells8101133 · Cited by 59
Relationship between IL-10 and tumor markers in breast cancer patients
Fernández, L. L., Goyanes, R. I. Á., Arango-Prado, M. D. C., Alcocer-González, J. M., Mojarrieta, J. C., Pérez, X. E., López, M. O., Odio, S. F., Rodríguez, R. C., Guerra-Yi, M. E., et al. (2006) · The Breast · doi:10.1016/j.breast.2005.09.012 · Cited by 58
Kilinc, M. O., Gu, T., Harden, J. L., Virtuoso, L. P., & Egilmez, N. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802793 · Cited by 57
Regulation of Lymphoid Homeostasis by IL-2 Receptor Signals In Vivo
Leung, D. T. M., Morefield, S., & Willerford, D. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3527 · Cited by 56
Naldini, A., Filippi, I., Miglietta, D., Moschetta, M., Giavazzi, R., & Carraro, F. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.044 · Cited by 55
Glynn, P. C., Henney, E., & Hall, I. P. (2002) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0323 · Cited by 55
Chen, S., Lian, G., Li, J., Zhang, Q., Zeng, L., Yang, K., Huang, C., Li, Y., Chen, Y., & Huang, K. (2018) · Cancer Medicine · doi:10.1002/cam4.1824 · Cited by 55
Cohen-Hillel, E., Yron, I., Meshel, T., Soria, G., Attal, H., & Ben‐Baruch, A. (2006) · Cytokine · doi:10.1016/j.cyto.2005.11.006 · Cited by 54
Mon, N. N., Senga, T., & Ito, S. (2016) · Oncology Letters · doi:10.3892/ol.2016.5521 · Cited by 54
Zou, Q., Jin, J., Xiao, Y., Zhou, X., Hu, H., Cheng, X., Kazimi, N., Ullrich, S. E., & Sun, S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.046 · Cited by 53
Human neutrophils activated via TLR8 promote Th17 polarization through IL-23
Tamassia, N., Arruda-Silva, F., Wright, H. L., Moots, R. J., Gardiman, E., Bianchetto-Aguilera, F. M., Gasperini, S., Capone, M., Maggi, L., Annunziato, F., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.ma0818-308r · Cited by 53
Leptin regulates energy metabolism in MCF-7 breast cancer cells
Blanquer-Rosselló, M. D. M., Oliver, J., Sastre‐Serra, J., Valle, A., & Roca, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.01.002 · Cited by 52
Circulating Colony Stimulating Factor-1 and Breast Cancer Risk
Tamimi, R. M., Brugge, J. S., Freedman, M. L., Miron, A., Iglehart, J. D., Colditz, G. A., & Hankinson, S. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3234 · Cited by 51
The Role of Adipokines and Bone Marrow Adipocytes in Breast Cancer Bone Metastasis
Shin, E., & Koo, J. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144967 · Cited by 50
Pro-apototic and Anti-apoptotic Effects of Tumor Necrosis Factor in Tumor Cells
Aggarwal, B. B., & Takada, Y. (2005) · Springer eBooks · doi:10.1007/0-387-24361-5_5 · Cited by 49
Loss of IFNγ Receptor Is an Independent Prognostic Factor in Ovarian Cancer
Duncan, T. J., Rolland, P., Deen, S., Scott, I., Liu, D. T. Y., Spendlove, I., & Durrant, L. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2833 · Cited by 48
Solís-Martínez, R., Cancino-Marentes, M., Hernández-Flores, G., Ortiz-Lazareno, P., Mandujano-Álvarez, G., Cruz-Gálvez, C., Sierra-Díaz, E., Rodríguez-Padilla, C., Jave-Suárez, L. F., Aguilar-Lemarroy, A., et al. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.02.009 · Cited by 47 · cited 2×
“IL-6 Monocytes, macrophages, TAM [71,72], T cells, B cells, fibroblasts, CAFs [73,74], endothelial cells, and adipocytes [75–77] some cancer cells [78,79], myeloid-derived suppressor cells (MDSC), and CD4+ T cells Activated B, DCs, cells, T cells, CD4+ T, plasma cells, hematopoietic stem cells, cancer cells, macrophag…”
BackgroundVijay, V., Miller, R., Vue, G. S., Pezeshkian, M., Maywood, M. J., Ast, A. M., Drusbosky, L. M., Pompeu, Y. A., Salgado, A. D., Lipten, S. D., et al. (2019) · Leukemia Research · doi:10.1016/j.leukres.2019.106180 · Cited by 47
Targeting Adiponectin in Breast Cancer
Nehme, R., Diab‐Assaf, M., Decombat, C., Delort, L., & Caldefie‐Chezet, F. (2022) · Biomedicines · doi:10.3390/biomedicines10112958 · Cited by 47
Self-citationStreet, D. G., Kaufmann, A. M., Vaughan, A. T., Fisher, S. G., Hunter, M., Schreckenberger, C., Potkul, R. K., Gissmann, L., & Qiao, L. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4667 · Cited by 45
Habanjar, O., Diab‐Assaf, M., Caldefie‐Chezet, F., & Delort, L. (2022) · Biology · doi:10.3390/biology11020339 · Cited by 45
Self-citationLin, Z., Wu, L.-X., Xie, Y., Ou, X., Tian, P., Liu, X., Min, J., Wang, J., Chen, R., Chen, Y., et al. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.8352 · Cited by 44
Ning, Y., Feng, W., Cao, X., Ren, K., Quan, M., Chen, A., Xu, C., Qiu, Y., Cao, J., Li, X., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01958-y · Cited by 44
Franco‐Barraza, J., Valdivia‐Silva, J., Zamudio‐Meza, H., Castillo, A., García-Zepeda, E. A., Benítez-Bribiesca, L., & Meza, I. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.04.010 · Cited by 43
Espinoza‐Sánchez, N. A., Chimal-Ramírez, G. K., Mantilla, A., & Fuentes‐Pananá, E. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00205 · Cited by 43
Interleukin‐8 derived from local tissue‐resident stromal cells promotes tumor cell invasion
Welte, G., Alt, E., Devarajan, E., Krishnappa, S., Jotzu, C., & Song, Y. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20854 · Cited by 41
CXCL12 overexpression promotes the angiogenesis potential of periodontal ligament stem cells
Zhang, L., Zhou, Y., Sun, X., Zhou, J. F., & Yang, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-10971-1 · Cited by 41
Leptin induces ROS via NOX5 in healthy and neoplastic mammary epithelial cells
Mahbouli, S., Vartanian, A. D., Ortega, S., Rougé, S., Vasson, M., & Rossary, A. (2017) · Oncology Reports · doi:10.3892/or.2017.6009 · Cited by 41
IL-1β in breast cancer bone metastasis
Zhou, J., Tulotta, C., & Ottewell, P. D. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.4 · Cited by 41
Leptin promotes the tyrosine phosphorylation of SHC proteins and SHC association with GRB2
Gualillo, O., Eirás, S., White, D. W., Diéguez, C., & Casanueva, F. F. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00012-6 · Cited by 40
Hosking, M., Flynn, C. T., & Whitton, J. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400348 · Cited by 40
Solution NMR characterization of WT CXCL 8 monomer and dimer binding to CXCR 1 N ‐terminal domain
Joseph, P. R. B., & Rajarathnam, K. (2014) · Protein Science · doi:10.1002/pro.2590 · Cited by 38
Cited by
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
Metadata
- Authors
- Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-02-16
- Volume
- 24
- Issue
- 4
- Pages
- 4002
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4321092565
- Cited by
- 263
- References
- 426
- FWCI
- 23.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.